Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	1,227	$977.38	786,762
Dec 13, 2017	YANCOPOULOS GEORGE Director, President & CSO Trans History: 673	Director, President & CSO	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	195,438	$21.92	786,786
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	4,886	$976.52	787,989
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	9,242	$975.48	792,875
Feb 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	123,601	$953.83	801,608
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	7,611	$974.51	802,117
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	2,653	$973.80	809,728
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	790	$972.22	812,381
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	4,922	$971.56	813,171
May 16, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	4,669	$970.26	818,093

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media